Criteria Fulfill
Item
the following selection criteria must be followed for patients entering the noninterventional study (nis):
boolean
C0243161 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
Indication Rotigotine Transdermal Patch | Intolerance to Dopamine Agonists Other | Lack of Efficacy Dopamine Agonists Other
Item
the decision by the treating physician to prescribe rotigotine transdermal patch is made before participating in the nis due to a clinical therapeutic indication (e.g., because of intolerance and/or ineffectiveness of another dopamine agonist)
boolean
C3146298 (UMLS CUI [1,1])
C1700683 (UMLS CUI [1,2])
C2348814 (UMLS CUI [1,3])
C1744706 (UMLS CUI [2,1])
C0178601 (UMLS CUI [2,2])
C0205394 (UMLS CUI [2,3])
C0235828 (UMLS CUI [3,1])
C0178601 (UMLS CUI [3,2])
C0205394 (UMLS CUI [3,3])
Age
Item
the patient is either male or female and over 18 years of age
boolean
C0001779 (UMLS CUI [1])
Informed Consent | Informed Consent Patient Representative
Item
a patient data consent form is signed and dated by the patient or by the legal representative
boolean
C0021430 (UMLS CUI [1])
C0021430 (UMLS CUI [2,1])
C0030701 (UMLS CUI [2,2])
Parkinson Disease | Rotigotine Absent | Participation Questionnaire
Item
the patient has idiopathic parkinson's disease, has not received rotigotine within 28 days prior to the baseline visit and is willing to participate in questionnaire based assessments
boolean
C0030567 (UMLS CUI [1])
C1700683 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0679823 (UMLS CUI [3,1])
C0034394 (UMLS CUI [3,2])
Levodopa | Combined Modality Therapy | Dopamine Agonists | Exception Rotigotine
Item
the patient is receiving l-dopa as monotherapy or a combination therapy composed of l-dopa and a dopamine agonist other than rotigotine
boolean
C0023570 (UMLS CUI [1])
C0009429 (UMLS CUI [2])
C0178601 (UMLS CUI [3])
C1705847 (UMLS CUI [4,1])
C1700683 (UMLS CUI [4,2])
Levodopa | Disease Response
Item
the patient has been on l-dopa therapy for at least 6 months and is responding to initial l-dopa therapy
boolean
C0023570 (UMLS CUI [1])
C1704632 (UMLS CUI [2])
MDS-UPDRS - Hoehn and Yahr Stage
Item
the patient has a hoehn and yahr stage score of 1 to 4.
boolean
C3639483 (UMLS CUI [1])
Study Subject Participation Status | Investigational New Drugs | Investigational Medical Device
Item
patients will be excluded from the study if they have participated in a clinical study of a medication or a medical device within 3 months prior to baseline or if they are participating in a clinical study at the time of inclusion or have already participated in the current study.
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C2346570 (UMLS CUI [3])